U.S. community pharmacies as CLIA-waived facilities: Prevalence, dispersion, and impact on patient access to testing

Michael E. Klepser, Alex J. Adams, Paul Srnis, Matthew Mazzucco, Donald Klepser

Research output: Contribution to journalArticlepeer-review

32 Scopus citations

Fingerprint

Dive into the research topics of 'U.S. community pharmacies as CLIA-waived facilities: Prevalence, dispersion, and impact on patient access to testing'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases